XML 28 R9.htm IDEA: XBRL DOCUMENT v3.24.0.1Close
CONSOLIDATED STATEMENTS OF CASH FLOWS
12 Months Ended
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Cash flows from operations      
Income (loss) from continuing operations $ 2,663,000,000 $ (2,421,000,000) $ 1,295,000,000
Income from discontinued operations, net of tax 2,732,000,000 233,000,000 262,000,000
Income (loss) from continuing operations (69,000,000) (2,654,000,000) 1,033,000,000
Adjustments to reconcile net income (loss) to cash flows operations:      
Depreciation and amortization 1,263,000,000 1,380,000,000 867,000,000
Pension settlement and curtailment (gains) losses 1,000,000 (12,000,000) 2,000,000
Net periodic pension and other postretirement costs (19,000,000) 50,000,000 99,000,000
Deferred income taxes (499,000,000) (230,000,000) (161,000,000)
Stock compensation 133,000,000 153,000,000 146,000,000
Losses on debt extinguishments 0 0 5,000,000
Long-lived asset impairments 77,000,000 344,000,000 0
Other long-lived asset impairments 470,000,000 9,000,000 11,000,000
Goodwill impairments 0 2,812,000,000 0
Loss on product divestiture arrangement 0 54,000,000 0
Reclassification of cumulative translation loss to earnings 0 65,000,000 0
Loss on subsidiary liquidation 0 21,000,000 0
Other 77,000,000 (20,000,000) 81,000,000
Changes in balance sheet items:      
Accounts receivable, net (66,000,000) (125,000,000) (170,000,000)
Inventories (114,000,000) (367,000,000) (27,000,000)
Prepaid expenses and other current assets (40,000,000) (49,000,000) (35,000,000)
Accounts payable 107,000,000 (73,000,000) 105,000,000
Accrued expenses and other current liabilities 412,000,000 (221,000,000) 207,000,000
Other (31,000,000) (106,000,000) (137,000,000)
Cash flows from operations – continuing operations 1,702,000,000 1,031,000,000 2,026,000,000
Cash flows from operations – discontinued operations 24,000,000 180,000,000 196,000,000
Cash flows from operations 1,726,000,000 1,211,000,000 2,222,000,000
Cash flows from investing activities      
Capital expenditures (692,000,000) (620,000,000) (691,000,000)
Acquisitions, net of cash acquired, and investments (6,000,000) (263,000,000) (10,502,000,000)
Other investing activities, net 26,000,000 11,000,000 45,000,000
Cash flows from investing activities - continuing operations (672,000,000) (872,000,000) (11,148,000,000)
Cash flows from investing activities - discontinued operations 3,885,000,000 (59,000,000) (52,000,000)
Cash flows from investing activities - continuing operations 3,213,000,000 (931,000,000) (11,200,000,000)
Cash flows from financing activities      
Issuances of debt 0 0 11,903,000,000
Repayments of debt (2,634,000,000) (954,000,000) (2,823,000,000)
Net (decreases) increases in debt with original maturities of three months or less (299,000,000) 55,000,000 246,000,000
Cash dividends on common stock (586,000,000) (573,000,000) (530,000,000)
Proceeds from stock issued under employee benefit plans 95,000,000 127,000,000 187,000,000
Purchases of treasury stock 0 (32,000,000) (600,000,000)
Debt issuance costs 0 0 (98,000,000)
Other financing activities, net (65,000,000) (61,000,000) (40,000,000)
Cash flows from financing activities (3,489,000,000) (1,438,000,000) 8,245,000,000 Close
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash 26,000,000 (76,000,000) (47,000,000) Close
Increase (decrease) in cash, cash equivalents and restricted cash 1,476,000,000 (1,234,000,000) (780,000,000) Close
Cash, cash equivalents and restricted cash at beginning of year 1,722,000,000 [1] 2,956,000,000 [1] 3,736,000,000 [1]
Cash, cash equivalents and restricted cash at end of year 3,198,000,000 [1] 1,722,000,000 [1] 2,956,000,000 [1]
Cash and cash equivalents 3,194,000,000 1,718,000,000 2,951,000,000
Restricted cash included in prepaid expenses and other current assets $ 4,000,000 $ 4,000,000 $ 5,000,000
[1] The following table provides a reconciliation of cash, cash equivalents and restricted cash amounts as shown in the consolidated statement of cash flows to the amount reported in the consolidated balance sheet as of December 31, 2023, 2022, and 2021:
As of December 31 (in millions)202320222021
Cash and cash equivalents$3,194 $1,718 $2,951 
Restricted cash included in prepaid expenses and other current assets
Cash, cash equivalents and restricted cash$3,198 $1,722 $2,956